Journal details
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
ELSEVIER SCIENCE INC · ISSN 1040-8428 · eISSN 1879-0461
SCIEScopusMEDLINEPubMedPMC
Overview
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. ISSN 1040-8428 · eISSN 1879-0461. published by ELSEVIER SCIENCE INC. United States. Oncology · Hematology. impact factor 6.2 (2025). JCR Q1. CAS Zone 2 TOP. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 255 articles · 2025: 417 articles · 2024: 280 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY?
The impact factor recorded for CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY is 6.2 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY?
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY is listed in CAS Zone 2 and marked as a TOP journal.
Which databases index CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY?
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.